Bristol-Myers Squibb Co (MIL:1BMY) Institutional Ownership : 53.20% (As of May. 19, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Bristol-Myers Squibb Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bristol-Myers Squibb Co's institutional ownership is 53.20%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bristol-Myers Squibb Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bristol-Myers Squibb Co's Float Percentage Of Total Shares Outstanding is 99.89%.

Bristol-Myers Squibb Co Institutional Ownership Historical Data

The historical data trend for Bristol-Myers Squibb Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Institutional Ownership Chart

Bristol-Myers Squibb Co Historical Data

The historical data trend for Bristol-Myers Squibb Co can be seen below:

	2023-06-30	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31
Institutional Ownership	55.78	55.45	54.79	57.25	53.54	53.45	53.00	51.55	51.40	53.20

Bristol-Myers Squibb Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Bristol-Myers Squibb Co (MIL:1BMY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (MIL:1BMY) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico BRMd:UK 0R1F:UK BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (MIL:1BMY) Headlines

No Headlines